NOVO HOLDINGS A/S
CIK 1388325 · View on SEC EDGAR ↗
- Portfolio value
- $1.7B
- Positions
- 25
- As of
- June 30, 2026
Portfolio value QoQ: +39.5% 13F does not disclose cash
- Top 10 holdings weight
- 73.48%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 22
- Effective number of positions
- 14.4
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 11.55% Est. buys $396,823,450 · sells $170,802,679
Median holding: 4.0 quarters Tracked Q4 2024–Q2 2026 · 54.3% still held
- New positions
- 6
- Increased
- 2
- Decreased
- 8
- Closed
- 3
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Full portfolio 25 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $217,370,500 | 12.62% | 5,350,000 | $48,845,500 | |||
| ASML ASML Holding N.V. - New York Registry Shares | $188,889,370 | 10.97% | 94,946 | $63,481,845 | |||
| Unknown issuer (CUSIP: 423494103) | $153,551,602 | 8.92% | 4,180,550 | Up ×1 | |||
| BN Brookfield Corporation Class A Limited Voting Shares | $149,534,399 | 8.68% | 3,496,245 | $8,041,364 | |||
| MPLT MapLight Therapeutics, Inc. - Common Stock | $132,128,532 | 7.67% | 3,686,622 | $57,179,507 | |||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $131,703,750 | 7.65% | 1,125,000 | $9,300,250 | Down ×1 | ||
| Unknown issuer (CUSIP: 05348Y105) | $127,837,874 | 7.42% | 3,883,289 | Up ×1 | |||
| CRM Salesforce, Inc. Common Stock | $61,596,675 | 3.58% | 393,187 | $-11,799,542 | |||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $52,110,000 | 3.03% | 1,500,000 | $7,304,784 | Down ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $50,750,000 | 2.95% | 1,000,000 | $574,000 | Down ×2 | ||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $49,394,400 | 2.87% | 1,320,000 | $-6,901,600 | Down ×2 | ||
| PHVS Pharvaris N.V. - Ordinary Shares | $48,412,000 | 2.81% | 1,400,000 | $-1,025,500 | Down ×1 | ||
| FND Floor & Decor Holdings, Inc. Common Stock | $47,309,920 | 2.75% | 797,000 | Up ×1 | |||
| PCVX Vaxcyte, Inc. - Common Stock | $46,504,000 | 2.70% | 800,000 | $-3,470,600 | Down ×2 | ||
| FDMT 4D Molecular Therapeutics, Inc. - Common Stock | $43,214,067 | 2.51% | 3,249,178 | $9,225,706 | Down ×1 | ||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $39,219,950 | 2.28% | 2,135,000 | $99,950 | Up ×1 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $38,140,250 | 2.21% | 1,025,000 | $76,250 | Down ×1 | ||
| ALMS Alumis Inc. - Common Stock | $30,954,000 | 1.80% | 1,100,000 | Up ×1 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $29,301,038 | 1.70% | 485,438 | $1,072,818 | |||
| BABA Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share | $24,698,245 | 1.43% | 257,327 | $-7,586,000 | |||
| DYN Dyne Therapeutics, Inc. - Common Stock | $21,330,351 | 1.24% | 960,394 | Up ×1 | |||
| BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | $17,145,000 | 1.00% | 2,250,000 | $-2,419,011 | Up ×2 | ||
| INSM Insmed Incorporated - Common Stock | $12,871,486 | 0.75% | 120,723 | ||||
| MQ Marqeta, Inc. - Class A Common Stock | $7,170,902 | 0.42% | 441,558 | $5,369,345 | |||
| LNZA LanzaTech Global, Inc. - Common Stock | $1,078,569 | 0.06% | 158,148 | $-1,453,380 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| ASML | Price move only | +0 | +$63.5M |
| MPLT | Price move only | +0 | +$57.2M |
| EWTX | Price move only | +0 | +$48.8M |
| CRM | Price move only | +0 | -$11.8M |
| MIRM | Trimmed | -200K | +$9.3M |
| FDMT | Trimmed | -402K | +$9.2M |
| BN | Price move only | +0 | +$8.0M |
| BABA | Price move only | +0 | -$7.6M |
| AVBP | Trimmed | -442K | +$7.3M |
| CRNX | Trimmed | -230K | -$6.9M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| VTI | Dec. 31, 2025 | 1,038,550 | $340,820,954 | No longer tracked |
| TEM | March 31, 2025 | 4,074,419 | $137,552,385 | 37.6% |
| MRUS | Dec. 31, 2025 | 750,000 | $70,612,500 | No longer tracked |
| ZBIO | March 31, 2026 | 1,450,000 | $52,649,500 | 63.2% |
| RXRX | Dec. 31, 2025 | 7,929,835 | $38,697,595 | -17.0% |
| APGE | June 30, 2026 | 450,000 | $37,876,500 | 1.6% |
| BMRN | June 30, 2026 | 660,000 | $37,283,400 | 18.2% |
| INSM | March 31, 2026 | 200,000 | $34,808,000 | -23.3% |
| BPMC | Sept. 30, 2025 | 264,956 | $33,962,060 | No longer tracked |
| CRGX | March 31, 2025 | 1,663,724 | $23,990,900 | No longer tracked |
| FOLD | June 30, 2025 | 2,750,000 | $22,440,000 | No longer tracked |
| CBLL | Sept. 30, 2025 | 900,000 | $16,857,000 | 108.4% |
| VERV | June 30, 2025 | 3,000,000 | $13,710,000 | No longer tracked |
| RCKT | June 30, 2025 | 1,100,000 | $7,337,000 | 44.1% |
| VALN | June 30, 2026 | 1,057,421 | $6,608,881 | 31.5% |
| MRSN | March 31, 2025 | 4,250,000 | $6,077,500 | No longer tracked |
| LXEO | June 30, 2025 | 1,122,581 | $3,895,356 | 28.0% |
| KYTX | June 30, 2025 | 1,850,000 | $3,570,500 | 170.2% |
| ABCL | Sept. 30, 2025 | 652,529 | $2,238,174 | 126.6% |
| IOBT | March 31, 2026 | 2,512,453 | $1,529,833 | No longer tracked |
| GLTO | Dec. 31, 2025 | 86,579 | $322,074 | No longer tracked |